New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report

The 2019 new coronavirus (SARS-CoV-2) is a novel respiratory virus which has increasingly spread all over the world. Although the predominant clinical presentation is represented by respiratory symptoms, neurological manifestation of SARS-CoV-2 is being increasingly recognized. In the present report...

Descripción completa

Detalles Bibliográficos
Autores principales: Dono, Fedele, Carrarini, Claudia, Russo, Mirella, De Angelis, Maria Vittoria, Anzellotti, Francesca, Onofrj, Marco, Bonanni, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608104/
https://www.ncbi.nlm.nih.gov/pubmed/33145624
http://dx.doi.org/10.1007/s10072-020-04846-z
Descripción
Sumario:The 2019 new coronavirus (SARS-CoV-2) is a novel respiratory virus which has increasingly spread all over the world. Although the predominant clinical presentation is represented by respiratory symptoms, neurological manifestation of SARS-CoV-2 is being increasingly recognized. In the present report, we present a case of post SARS-CoV-2 autoimmune encephalitis associated with a new-onset refractory status epilepticus (NORSE). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10072-020-04846-z.

Ejemplares similares